Research How Gene Mutation Leads to Follicular Lymphoma A recent discovery revealed that a gene called KMT2D does not directly drive uncontrolled cell…adminOctober 5, 2015
Research Brentuximab vedotin in elderly Hodgkin lymphoma patients A study published in the ASH Blood Journal in June 2015 reports that bretuximab vedotin…adminSeptember 22, 2015
News Roveena is Ambassador for Lymphoma Canada On September 1, Roveena and Lymphoma Canada announced that she will be joining the team…adminSeptember 9, 2015
Press Releases Roveena Partners with Lymphoma Canada & Launches Music Video on World Lymphoma Awareness Day For immediate release September 8, 2015 ROVEENA PARTNERS WITH LYMPHOMA CANADA & LAUNCHES MUSIC VIDEO…adminSeptember 8, 2015
NewsPress Releases Dynacare Selects Lymphoma Canada as 2015 Lead Charity Lymphoma Canada will receive a $25,000 donation to be directed toward research to improve the…adminSeptember 2, 2015
Research New Obinutuzumab Study Published Obinutuzumab (Gazyva) improved overall response and had acceptable toxicity compared with rituximab (Rituxan) in patients…adminAugust 25, 2015
Research Brentuximab Vedotin as Second-Line Therapy before Autologous Transplantation Brentuximab Vedotin is Effective as Salvage Therapy in Patients with Relapsed/Refractory Hodgkin Lymphoma Prior to…adminAugust 17, 2015
Research BC Cancer Agency Researchers Develop Improved Prognostic Test for Follicular Lymphoma Mutation patterns in seven genes may help predict outcomes for individuals with follicular lymphoma (more…)adminAugust 10, 2015
NewsResearch Health Canada Approves ibrutinib for Mantle Cell Lymphoma Health Canada has issued a Notice of Compliance with Conditions (NOC/c) for ibrutinib (Imbruvica®), a…adminJuly 31, 2015
News Matt’s Head-Shaving Fundraiser The head-shaving event at their house raised $1,800 with over 35 people attending and 16…adminJuly 30, 2015